MFG - OUR PHYSICIANS

Salvatore J. Lombardi, M.D. Salvatore J. Lombardi, M.D., founding partner of our group, received his fellowship training in maternal fetal medicine at Vanderbilt University Medical Center, where he was co-founder of the CVS program and was the first physician to perform chorionic villus sampling, both transcervical and transabdominal. He remained on the full-time academic faculty until 1992, during which time he received numerous awards to include the prestigious American College of Obstetricians and Gynecologists, Purdue Frederick Award for Excellence in Medical Research. Dr. Lombardi was one of the innovators in the field of obstetric Doppler velocimetry, presenting his work both nationally and internationally. He is published in the fields of both ultrasound and genetics. He received the Outstanding Community Hospital Research Award for his work in the area of genetics at the 1994 meeting of the Society of Perinatal Obstetricians.

Dr. Lombardi's academic and administrative appointments include Assistant Professor, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Vanderbilt University Medical Center; founder and director of the Division of Maternal Fetal Medicine, Baptist Hospital, Nashville, TN; Director, Vanderbilt University OBGYN residency at Baptist Hospital; Director of Ultrasound, Division of Maternal Fetal Medicine, Baptist Hospital; Director of Obstetrics, Metropolitan Nashville General Hospital, Nashville, TN; Assistant Professor, Meharry Medical College, Nashville, TN; and Clinical Director, Maternal Infant-Childcare Program, Nashville, TN. His areas of special interest and expertise include chorionic villus sampling, fetal anomalies, Doppler velocimetry and prenatal genetic diagnoses.

Dr. Lombardi graduated from the University of Nuevo Leon, Monterrey, Mexico. He received his fellowship training at Vanderbilt University and completed his residency at State University of New York, Buffalo, NY. Dr. Lombardi is board-certified in Obstetrics and Gynecology as well as Maternal Fetal Medicine.

Stephen J. Fortunato, M.D., is a Senior Partner of Maternal Fetal Group. His maternal fetal fellowship training was at Parkland Hospital in Dallas. He held faculty positions at East Tennessee State University; and Wright State University School of Medicine where he was Vice Chairman, Director of OBICU. He came to our group from Tulane University School of Medicine where he was Section Chief of Maternal Fetal Medicine, Director of OBICU and Director of Maternity Service for the Tulane Medical Center.

Dr. Fortunato has been published and won international acclaim for his work on placental transport, premature rupture of the membranes and the molecular basis of prematurity. His research has won national and international awards from ACOG, the Society of Perinatal Obstetricians, the Society of Gynecologic Investigation, the Society of the Fetus as a Patient and the Central Association of Obstetricians & Gynecologists. He serves as Medical Director of the Perinatal Risk Management Program for HCA. Additionally, he serves as Chairman of the Board and CEO of Proterm, a newly formed pharmaceutical company. He is Director of Maternal Fetal Medicine at the Women's Hospital at Centennial Medical Center.

Dr. Fortunato is a reviewer for Obstetrics and Gynecology, American Journal of OBGYN and sits on study sections for the National Institute of Health and the New Zealand Health Research Council. His clinical interests include echocardiography, medical complications of pregnancy, invasive fetal procedures and prematurity.

Dr. Fortunato graduated from University of Cincinnati. He received his fellowship training at University of Texas Southwestern and completed his residency at the University of New Mexico. Dr. Fortunato is board-certified in Obstetrics and Gynecology, as well as Maternal Fetal Medicine.

Michael DeRoche, M.D. Michael E. DeRoche, M.D. joined us in August of 2003 after completing his Maternal Fetal Fellowship at the University of Connecticut. Dr. DeRoche received his medical degree from the Wake Forest University - Bowman Gray School of Medicine and completed his residency at Hartford Hospital in Hartford, Connecticut where he received research and performance awards in 1998, 1999 and 2000.

Dr. DeRoche is board-eligible in Obstetrics & Gynecology and Maternal Fetal Medicine. He is published in the American Journal of OBGyn, Obstetrics & Gynecology and the British Journal of Obestetrics & Gynecology. He has presented over 20 abstracts to professional societies. The published topics include amniocentesis, Down Syndrome and fetal lung maturity testing in diabetic pregnancies.

Dr. DeRoche’s clinical interests and expertise include fetal echocardiography, prenatal genetic diagnoses as well as fetal lung maturity testing.

In a prior career, Dr. DeRoche was Vice President of the preferred stock department at the investment banking firm, Drexel Burnham Lambert in Beverly Hills, California.

We are pleased to have a physician of Dr. DeRoche’s caliber join our group.

Paul D. Speer, M.D. is the newest member of Maternal Fetal Group.
Dr. Speer received his medical degree and completed his residency on Obstetrics and Gynecology at Louisiana State University Health Sciences Center in Shreveport, Louisiana. He joins us after recently completing a Maternal Fetal Medicine Fellowship at the University of Pittsburgh, Magee-Womens Hospital in Pittsburgh, Pennsylvania.

While at Magee-Womens Hospital, Dr. Speer conducted research in preeclampsia and intrauterine growth restriction, as well as research in diabetes in pregnancy. His research has been presented at numerous national and international meetings, and in 2000, he received the Excellence in Research Award from the Society of Maternal Fetal Medicine. Dr. Speer's clinical interests include preeclampsia, fetal growth restriction, diabetes in pregnancy, fetal echocardiology, maternal clotting disorders and thrombophilias and prenatal diagnosis.

During his residency and fellowship, Dr. Speer has received numerous performance and teaching awards, and was recently awarded the Outstanding Teaching Fellow in Obstetrics, Gynecology and Reproductive Sciences at Magee-Womens Hospital.


	Salvatore J. Lombardi, M.D., founding partner of our group, received his fellowship training in maternal fetal medicine at Vanderbilt University Medical Center, where he was co-founder of the CVS program and was the first physician to perform chorionic villus sampling, both transcervical and transabdominal. He remained on the full-time academic faculty until 1992, during which time he received numerous awards to include the prestigious American College of Obstetricians and Gynecologists, Purdue Frederick Award for Excellence in Medical Research. Dr. Lombardi was one of the innovators in the field of obstetric Doppler velocimetry, presenting his work both nationally and internationally. He is published in the fields of both ultrasound and genetics. He received the Outstanding Community Hospital Research Award for his work in the area of genetics at the 1994 meeting of the Society of Perinatal Obstetricians. Dr. Lombardi's academic and administrative appointments include Assistant Professor, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Vanderbilt University Medical Center; founder and director of the Division of Maternal Fetal Medicine, Baptist Hospital, Nashville, TN; Director, Vanderbilt University OBGYN residency at Baptist Hospital; Director of Ultrasound, Division of Maternal Fetal Medicine, Baptist Hospital; Director of Obstetrics, Metropolitan Nashville General Hospital, Nashville, TN; Assistant Professor, Meharry Medical College, Nashville, TN; and Clinical Director, Maternal Infant-Childcare Program, Nashville, TN. His areas of special interest and expertise include chorionic villus sampling, fetal anomalies, Doppler velocimetry and prenatal genetic diagnoses. Dr. Lombardi graduated from the University of Nuevo Leon, Monterrey, Mexico. He received his fellowship training at Vanderbilt University and completed his residency at State University of New York, Buffalo, NY. Dr. Lombardi is board-certified in Obstetrics and Gynecology as well as Maternal Fetal Medicine. Stephen J. Fortunato, M.D., is a Senior Partner of Maternal Fetal Group. His maternal fetal fellowship training was at Parkland Hospital in Dallas. He held faculty positions at East Tennessee State University; and Wright State University School of Medicine where he was Vice Chairman, Director of OBICU. He came to our group from Tulane University School of Medicine where he was Section Chief of Maternal Fetal Medicine, Director of OBICU and Director of Maternity Service for the Tulane Medical Center. Dr. Fortunato has been published and won international acclaim for his work on placental transport, premature rupture of the membranes and the molecular basis of prematurity. His research has won national and international awards from ACOG, the Society of Perinatal Obstetricians, the Society of Gynecologic Investigation, the Society of the Fetus as a Patient and the Central Association of Obstetricians & Gynecologists. He serves as Medical Director of the Perinatal Risk Management Program for HCA. Additionally, he serves as Chairman of the Board and CEO of Proterm, a newly formed pharmaceutical company. He is Director of Maternal Fetal Medicine at the Women's Hospital at Centennial Medical Center. Dr. Fortunato is a reviewer for Obstetrics and Gynecology, American Journal of OBGYN and sits on study sections for the National Institute of Health and the New Zealand Health Research Council. His clinical interests include echocardiography, medical complications of pregnancy, invasive fetal procedures and prematurity. Dr. Fortunato graduated from University of Cincinnati. He received his fellowship training at University of Texas Southwestern and completed his residency at the University of New Mexico. Dr. Fortunato is board-certified in Obstetrics and Gynecology, as well as Maternal Fetal Medicine. Michael E. DeRoche, M.D. joined us in August of 2003 after completing his Maternal Fetal Fellowship at the University of Connecticut. Dr. DeRoche received his medical degree from the Wake Forest University - Bowman Gray School of Medicine and completed his residency at Hartford Hospital in Hartford, Connecticut where he received research and performance awards in 1998, 1999 and 2000. Dr. DeRoche is board-eligible in Obstetrics & Gynecology and Maternal Fetal Medicine. He is published in the American Journal of OBGyn, Obstetrics & Gynecology and the British Journal of Obestetrics & Gynecology. He has presented over 20 abstracts to professional societies. The published topics include amniocentesis, Down Syndrome and fetal lung maturity testing in diabetic pregnancies. Dr. DeRoche’s clinical interests and expertise include fetal echocardiography, prenatal genetic diagnoses as well as fetal lung maturity testing. In a prior career, Dr. DeRoche was Vice President of the preferred stock department at the investment banking firm, Drexel Burnham Lambert in Beverly Hills, California. We are pleased to have a physician of Dr. DeRoche’s caliber join our group. Paul D. Speer, M.D. is the newest member of Maternal Fetal Group. Dr. Speer received his medical degree and completed his residency on Obstetrics and Gynecology at Louisiana State University Health Sciences Center in Shreveport, Louisiana. He joins us after recently completing a Maternal Fetal Medicine Fellowship at the University of Pittsburgh, Magee-Womens Hospital in Pittsburgh, Pennsylvania. While at Magee-Womens Hospital, Dr. Speer conducted research in preeclampsia and intrauterine growth restriction, as well as research in diabetes in pregnancy. His research has been presented at numerous national and international meetings, and in 2000, he received the Excellence in Research Award from the Society of Maternal Fetal Medicine. Dr. Speer's clinical interests include preeclampsia, fetal growth restriction, diabetes in pregnancy, fetal echocardiology, maternal clotting disorders and thrombophilias and prenatal diagnosis. During his residency and fellowship, Dr. Speer has received numerous performance and teaching awards, and was recently awarded the Outstanding Teaching Fellow in Obstetrics, Gynecology and Reproductive Sciences at Magee-Womens Hospital.
	Services \| Insurance \| Directions \| Our Physicians \| Accreditation \| Links \| Home Copyright ©2001 Maternal Fetal Group P.L.L.C. All Rights Reserved.